Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Safety and Performance of the Dynalink®-E, Everolimus Eluting Peripheral Stent System for Treating Atherosclerotic de Novo or Restenotic Native Superficial Femoral and Proximal Popliteal Artery Lesions

NCT00475566 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT00475566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00475566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Safety and Performance of the Dynalink®-E, Everolimus Eluting Peripheral Stent System for Treating Atherosclerotic de Novo or Restenotic Native Superficial Femoral and Proximal Popliteal Artery Lesions
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2007
Completion date
February 28, 2010
Enrollment
104 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, peripheral vascular disease